Revenio Group Corporation (REG1V) - Net Assets
Based on the latest financial reports, Revenio Group Corporation (REG1V) has net assets worth €117.30 Million EUR (≈ $137.14 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€148.20 Million ≈ $173.26 Million USD) and total liabilities (€30.90 Million ≈ $36.13 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. For live market cap and overall valuation, see REG1V market cap.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €117.30 Million |
| % of Total Assets | 79.15% |
| Annual Growth Rate | 6.91% |
| 5-Year Change | 46.25% |
| 10-Year Change | 666.3% |
| Growth Volatility | 67.51 |
Revenio Group Corporation - Net Assets Trend (2000–2025)
This chart illustrates how Revenio Group Corporation's net assets have evolved over time, based on quarterly financial data.
Annual Net Assets for Revenio Group Corporation (2000–2025)
The table below shows the annual net assets of Revenio Group Corporation from 2000 to 2025. See Revenio Group Corporation balance sheet quality to measure how much of total assets are equity-financed.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €114.70 Million ≈ $134.10 Million |
+6.49% |
| 2024-12-31 | €107.71 Million ≈ $125.92 Million |
+7.82% |
| 2023-12-31 | €99.89 Million ≈ $116.79 Million |
+9.87% |
| 2022-12-31 | €90.92 Million ≈ $106.29 Million |
+15.92% |
| 2021-12-31 | €78.43 Million ≈ $91.69 Million |
+12.51% |
| 2020-12-31 | €69.71 Million ≈ $81.50 Million |
+8.31% |
| 2019-12-31 | €64.36 Million ≈ $75.25 Million |
+256.17% |
| 2018-12-31 | €18.07 Million ≈ $21.13 Million |
+13.03% |
| 2017-12-31 | €15.99 Million ≈ $18.69 Million |
+6.81% |
| 2016-12-31 | €14.97 Million ≈ $17.50 Million |
-0.43% |
| 2015-12-31 | €15.03 Million ≈ $17.58 Million |
+24.64% |
| 2014-12-31 | €12.06 Million ≈ $14.10 Million |
-19.36% |
| 2013-12-31 | €14.96 Million ≈ $17.49 Million |
+1.91% |
| 2012-12-31 | €14.68 Million ≈ $17.16 Million |
-10.66% |
| 2011-12-31 | €16.43 Million ≈ $19.20 Million |
+13.28% |
| 2010-12-31 | €14.50 Million ≈ $16.95 Million |
-7.87% |
| 2009-12-31 | €15.74 Million ≈ $18.40 Million |
-10.52% |
| 2008-12-31 | €17.59 Million ≈ $20.56 Million |
-20.83% |
| 2007-12-31 | €22.22 Million ≈ $25.98 Million |
+102.72% |
| 2006-12-31 | €10.96 Million ≈ $12.81 Million |
+118.46% |
| 2005-12-31 | €5.02 Million ≈ $5.87 Million |
+132.65% |
| 2004-12-31 | €2.16 Million ≈ $2.52 Million |
+95.66% |
| 2003-12-31 | €1.10 Million ≈ $1.29 Million |
-74.49% |
| 2002-12-31 | €4.32 Million ≈ $5.05 Million |
-46.35% |
| 2001-12-31 | €8.05 Million ≈ $9.42 Million |
-54.55% |
| 2001-09-30 | €17.72 Million ≈ $20.72 Million |
-17.81% |
| 2000-12-31 | €21.56 Million ≈ $25.21 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Revenio Group Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2969900.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €59.40 Million | 51.79% |
| Common Stock | €5.30 Million | 4.62% |
| Other Comprehensive Income | €-700.00K | -0.61% |
| Other Components | €50.70 Million | 44.20% |
| Total Equity | €114.70 Million | 100.00% |
Revenio Group Corporation Competitors by Market Cap
The table below lists competitors of Revenio Group Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hangzhou Coco Healthcare Products Co.Ltd.
SHE:301009
|
$359.23 Million |
|
KNOT Offshore Partners LP
NYSE:KNOP
|
$359.49 Million |
|
Seanergy Maritime Holdings Corp
NASDAQ:SHIP
|
$359.69 Million |
|
Gladstone Land Corporation
NASDAQ:LAND
|
$359.76 Million |
|
Shandong Cynda Chemcial Co Ltd
SHG:603086
|
$358.86 Million |
|
Guangdong Failong Crystal Technology Co Ltd
SHE:300460
|
$358.72 Million |
|
SMS Electric Co Ltd Zhengzhou
SHE:002857
|
$358.61 Million |
|
CPH Chemie und Papier Holding
SW:CPHN
|
$358.50 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Revenio Group Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 107,709,000 to 114,700,000, a change of 6,991,000 (6.5%).
- Net income of 17,400,000 contributed positively to equity growth.
- Dividend payments of 10,600,000 reduced retained earnings.
- Other comprehensive income decreased equity by 52,563,000.
- Other factors increased equity by 52,754,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €17.40 Million | +15.17% |
| Dividends Paid | €10.60 Million | -9.24% |
| Other Comprehensive Income | €-52.56 Million | -45.83% |
| Other Changes | €52.75 Million | +45.99% |
| Total Change | €- | 6.49% |
Book Value vs Market Value Analysis
This analysis compares Revenio Group Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.41x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 39.50x to 3.41x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | €0.37 | €14.72 | x |
| 2003-12-31 | €0.07 | €14.72 | x |
| 2004-12-31 | €0.15 | €14.72 | x |
| 2005-12-31 | €0.27 | €14.72 | x |
| 2008-12-31 | €0.77 | €14.72 | x |
| 2009-12-31 | €0.68 | €14.72 | x |
| 2010-12-31 | €0.63 | €14.72 | x |
| 2011-12-31 | €0.70 | €14.72 | x |
| 2012-12-31 | €0.63 | €14.72 | x |
| 2013-12-31 | €0.63 | €14.72 | x |
| 2014-12-31 | €0.51 | €14.72 | x |
| 2015-12-31 | €0.65 | €14.72 | x |
| 2016-12-31 | €0.66 | €14.72 | x |
| 2017-12-31 | €0.67 | €14.72 | x |
| 2018-12-31 | €0.76 | €14.72 | x |
| 2019-12-31 | €2.50 | €14.72 | x |
| 2020-12-31 | €2.62 | €14.72 | x |
| 2021-12-31 | €2.95 | €14.72 | x |
| 2022-12-31 | €3.42 | €14.72 | x |
| 2023-12-31 | €3.76 | €14.72 | x |
| 2024-12-31 | €4.05 | €14.72 | x |
| 2025-12-31 | €4.32 | €14.72 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Revenio Group Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 15.17%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 15.86%
- • Asset Turnover: 0.73x
- • Equity Multiplier: 1.31x
- Recent ROE (15.17%) is above the historical average (-2.38%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | -178.44% | -24.08% | 2.68x | 2.76x | €-8.14 Million |
| 2003 | -292.22% | -14.24% | 3.46x | 5.92x | €-3.33 Million |
| 2004 | -47.21% | -5.52% | 3.27x | 2.61x | €-1.23 Million |
| 2005 | 56.93% | 19.83% | 1.06x | 2.70x | €1.87 Million |
| 2006 | 31.52% | 24.17% | 0.83x | 1.57x | €2.36 Million |
| 2007 | 24.64% | 22.18% | 0.61x | 1.83x | €3.25 Million |
| 2008 | 15.15% | 5.90% | 1.56x | 1.65x | €906.00K |
| 2009 | -5.18% | -2.72% | 1.13x | 1.69x | €-2.39 Million |
| 2010 | -3.50% | -1.72% | 1.20x | 1.69x | €-1.96 Million |
| 2011 | 23.81% | 11.75% | 1.34x | 1.51x | €2.27 Million |
| 2012 | -1.96% | -1.13% | 1.02x | 1.70x | €-1.75 Million |
| 2013 | 29.00% | 16.86% | 1.14x | 1.51x | €2.84 Million |
| 2014 | -5.75% | -4.33% | 0.83x | 1.60x | €-1.90 Million |
| 2015 | 41.78% | 32.08% | 1.10x | 1.18x | €4.94 Million |
| 2016 | 35.45% | 23.83% | 1.23x | 1.20x | €4.01 Million |
| 2017 | 42.84% | 25.57% | 1.41x | 1.19x | €5.25 Million |
| 2018 | 44.84% | 26.43% | 1.39x | 1.22x | €6.30 Million |
| 2019 | 14.52% | 18.88% | 0.45x | 1.71x | €2.91 Million |
| 2020 | 19.17% | 21.88% | 0.53x | 1.64x | €6.39 Million |
| 2021 | 22.08% | 21.99% | 0.63x | 1.59x | €9.48 Million |
| 2022 | 23.93% | 22.43% | 0.71x | 1.50x | €12.66 Million |
| 2023 | 19.13% | 19.79% | 0.70x | 1.38x | €9.12 Million |
| 2024 | 17.17% | 17.87% | 0.73x | 1.31x | €7.73 Million |
| 2025 | 15.17% | 15.86% | 0.73x | 1.31x | €5.93 Million |
Industry Comparison
This section compares Revenio Group Corporation's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $6,600,269
- Average return on equity (ROE) among peers: -294.03%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Revenio Group Corporation (REG1V) | €117.30 Million | -178.44% | 0.26x | $358.98 Million |
| Biohit Oyj B (BIOBV) | $14.90 Million | 18.12% | 0.33x | $37.29 Million |
| BBS-Bioactive Bone Substitutes Oyj (BONEH) | $4.60 Million | -14.75% | 1.79x | $1.50 Million |
| Nexstim Oyj (NXTMH) | $304.81K | -885.46% | 12.00x | $80.54 Million |
About Revenio Group Corporation
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Sensors that are accessories of iCare tonometer for measuring intraocular pr… Read more